Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven D. Gillies
Steven D. Gillies
Carlisle Companies
Phases of clinical research
Toxicity
Bone marrow
Refractory
Neuroblastoma
2
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.
2020
Journal for ImmunoTherapy of Cancer
Jacob L Goldberg
Fariba Navid
Jacqueline A. Hank
Amy K. Erbe
Victor M. Santana
Jacek Gan
Fenna de Bie
Amal M. Javaid
Anna Hoefges
Michael Merdler
Lakeesha Carmichael
KyungMann Kim
Michael W. Bishop
Michael M Meager
Steven D. Gillies
Janardan P. Pandey
Paul M. Sondel
Show All
Source
Cite
Save
Citations (1)
Anti-tumor activity and tolerability of hu14.18-IL2 with GMCSF and isotretinoin in recurrent or refractory neuroblastoma: A Children's Oncology Group phase II study
2019
Clinical Cancer Research
Suzanne Shusterman
Arlene Naranjo
Collin Van Ryn
Hank Ja
Marguerite T. Parisi
Barry L. Shulkin
Sabah Servaes
Wendy B. London
Hiroyuki Shimada
Jacek Gan
Steven D. Gillies
John M. Maris
Julie R. Park
Paul M. Sondel
Show All
Source
Cite
Save
Citations (10)
1